JILL STRASSER: Open Payments
NPI 1083959803 · BRIDGEPORT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 120 payments from 16 companies in 2025. Trend: 2023 $1,724 · 2024 $1,934 · 2025 $1,890
Food & beverage: $1,890
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $561 |
| Alkermes, Inc. | 11 | $224 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $170 |
| Teva Pharmaceuticals USA, Inc. | 9 | $162 |
| Neurocrine BioSciences, Inc. | 6 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $53 |
| Axsome Therapeutics, Inc. | 3 | $42 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, TRINTELLIX, AUSTEDO XR, INGREZZA, REXULTI, SPRAVATO.
Industry payments across WV — which companies pay providers there.
